WT1 peptide‐based immunotherapy for advanced thymic epithelial malignancies
Y Oji, M Inoue, Y Takeda, N Hosen… - … journal of cancer, 2018 - Wiley Online Library
Thymic epithelial tumors are rare malignancies, and no optimal therapeutic regimen has
been defined for patients with advanced disease. Patients with advanced thymic epithelial
tumors, which were resistant or intolerable to prior therapies, were eligible for this study …
been defined for patients with advanced disease. Patients with advanced thymic epithelial
tumors, which were resistant or intolerable to prior therapies, were eligible for this study …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论